Arcutis Biotherapeutics, Inc. (ARQT) DCF Valuation

Arcutis Biotherapeutics, Inc. (ARQT) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Arcutis Biotherapeutics, Inc. (ARQT) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Whether you’re an investor or analyst, this (ARQT) DCF Calculator is your essential tool for accurate valuation. Preloaded with Arcutis Biotherapeutics, Inc. real data, you can adjust forecasts and observe the effects in real-time.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 3.7 59.6 74.5 93.1 116.4 145.5 181.9
Revenue Growth, % 0 0 0 0 1517.09 25 25 25 25 25
EBITDA -41.8 -135.2 -205.6 -294.6 -227.4 14.9 18.6 23.3 29.1 36.4
EBITDA, % 100 100 100 -7991.13 -381.56 20 20 20 20 20
Depreciation .2 .5 .8 1.3 1.9 50.2 62.8 78.5 98.1 122.7
Depreciation, % 100 100 100 33.99 3.16 67.43 67.43 67.43 67.43 67.43
EBIT -42.0 -135.7 -206.4 -295.8 -229.3 14.9 18.6 23.3 29.1 36.4
EBIT, % 100 100 100 -8025.12 -384.72 20 20 20 20 20
Total Cash 101.3 284.4 387.1 409.6 271.9 74.5 93.1 116.4 145.5 181.9
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .5 .0 8.5 25.8
Account Receivables, % 100 100 100 229.46 43.3
Inventories .0 -.5 1.2 7.5 13.1 62.9 78.6 98.3 122.8 153.5
Inventories, % 100 100 100 203.85 22.03 84.41 84.41 84.41 84.41 84.41
Accounts Payable 1.4 7.1 7.4 8.8 12.0 62.6 78.3 97.8 122.3 152.8
Accounts Payable, % 100 100 100 239.47 20.12 84.02 84.02 84.02 84.02 84.02
Capital Expenditure -.3 -.3 -1.0 -23.3 -.4 -15.0 -18.8 -23.5 -29.3 -36.6
Capital Expenditure, % 100 100 100 -631.66 -0.71805 -20.14 -20.14 -20.14 -20.14 -20.14
Tax Rate, % -1.2 -1.2 -1.2 -1.2 -1.2 -1.2 -1.2 -1.2 -1.2 -1.2
EBITAT -42.0 -135.7 -205.9 -305.1 -232.1 14.9 18.6 23.3 29.1 36.4
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -40.7 -129.8 -207.1 -340.5 -250.4 10.7 46.1 57.6 72.0 90.0
WACC, % 10.8 10.8 10.79 10.8 10.8 10.8 10.8 10.8 10.8 10.8
PV UFCF
SUM PV UFCF 191.2
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 92
Terminal Value 1,043
Present Terminal Value 625
Enterprise Value 816
Net Debt 118
Equity Value 699
Diluted Shares Outstanding, MM 69
Equity Value Per Share 10.08

What You Will Get

  • Real ARQT Financial Data: Pre-filled with Arcutis Biotherapeutics’ historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See Arcutis Biotherapeutics’ intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Real-Life ARQT Data: Pre-filled with Arcutis Biotherapeutics' historical financials and forward-looking projections.
  • Fully Customizable Inputs: Adjust revenue growth, margins, WACC, tax rates, and capital expenditures.
  • Dynamic Valuation Model: Automatic updates to Net Present Value (NPV) and intrinsic value based on your inputs.
  • Scenario Testing: Create multiple forecast scenarios to analyze different valuation outcomes.
  • User-Friendly Design: Simple, structured, and designed for professionals and beginners alike.

How It Works

  1. Download the Template: Gain immediate access to the Excel-based ARQT DCF Calculator.
  2. Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
  3. Instant Calculations: The model automatically recalculates Arcutis Biotherapeutics' intrinsic value.
  4. Test Scenarios: Experiment with different assumptions to assess potential changes in valuation.
  5. Analyze and Decide: Utilize the results to inform your investment or financial analysis.

Why Choose This Calculator for Arcutis Biotherapeutics, Inc. (ARQT)?

  • Designed for Experts: An advanced tool utilized by researchers, financial analysts, and industry professionals.
  • Accurate Data: Arcutis’ historical and forecasted financial information preloaded for precision.
  • Flexible Scenario Analysis: Effortlessly test various projections and assumptions.
  • Insightful Outputs: Automatically computes intrinsic value, NPV, and essential financial metrics.
  • User-Friendly: Comprehensive instructions lead you through each step of the calculation.

Who Should Use This Product?

  • Healthcare Professionals: Understand innovative dermatological treatments and their market potential.
  • Researchers: Utilize advanced models to study the efficacy of Arcutis' therapies in clinical settings.
  • Investors: Evaluate your investment strategies and analyze the market performance of Arcutis Biotherapeutics (ARQT).
  • Pharmaceutical Analysts: Enhance your analysis with a customizable model tailored to biopharmaceutical valuations.
  • Entrepreneurs: Discover how biopharmaceutical companies like Arcutis are assessed in the industry.

What the Template Contains

  • Preloaded ARQT Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

No products were found matching.